SCHEMBL7138482

SCHEMBL7138482

CCOP(=O)(OCC)C(=Cc1ccc(O)c2ccccc12)P(=O)(OCC)OCC

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NR1I2 O75469 3/20 0.57
HMGCR P04035 2/20 0.44
IDO1 P14902 4/20 0.37
GCGR P47871 3/20 0.37
CAPN1 P07384 2/20 0.37
CTSL P07711 2/20 0.37
CTSB P07858 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
POLB P06746 2/20 0.35
KDM4E B2RXH2 1/20 0.35
LMNA P02545 1/20 0.35
HPGD P15428 1/20 0.35
AOX1 Q06278 1/20 0.35
HDAC3 O15379 1/20 0.35
EP300 Q09472 1/20 0.35
KAT2B Q92831 1/20 0.35
KAT8 Q9H7Z6 1/20 0.35
NCOR2 Q9Y618 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9362475 0.89 NR1I2 (0.45) NR1I2HMGCRIDO1GCGRCAPN1
SCHEMBL9357630 0.87 NR1I2 (0.43) NR1I2IDO1GCGRCAPN1CTSL
SCHEMBL19279399 0.81 NR1I2 (0.66) NR1I2HMGCRMEN1KMT2AKDM4E
SCHEMBL9358736 0.80 HMGCR (0.44) NR1I2HMGCRIDO1GCGRCAPN1
SCHEMBL7759881 0.78 NR1I2 (0.54) NR1I2HMGCRGCGRMEN1KMT2A
SCHEMBL9484666 0.77 IDO1 (0.46) IDO1GCGRCAPN1CTSLCTSB
SCHEMBL7760639 0.77 NR1I2 (0.53) NR1I2HMGCRMEN1KMT2APOLB
SCHEMBL6942208 0.77 HMGCR (0.63) NR1I2HMGCRMEN1KMT2AKDM4E
SCHEMBL7079256 0.75 NR1I2 (0.48) NR1I2HMGCRMEN1KMT2APOLB
SCHEMBL19398053 0.74 NR1I2 (0.56) NR1I2HMGCRMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1326618-A2 USE OF ARYL-SUBSTITUTED 1,1-DIPHOSPHONATES FOR THE TREATMENT OF BONE DISEASES Ilex Oncology Research S.A. (CH) 2003-07-16 EP claimed
WO-2002011704-A2 USE OF ARYL-SUBSTITUTED 1,1-DIPHOSPHONATES FOR THE TREATMENT OF BONE DISEASES SYMPHAR S.A. (CH) 2002-02-14 WO claimed
EP-0418064-B1 Naphthalene and tetrahydronaphthalene gem-diphosphonate derivatives SYMPHAR SA (CH) 1994-12-14 EP disclosed
US-5204336-A Anticholestrol agents SYMPHAR S.A. (CH) 1993-04-20 US disclosed
EP-0418064-A2 Naphthalene and tetrahydronaphthalene gem-diphosphonate derivatives SYMPHAR S.A. (CH) 1991-03-20 EP disclosed